Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

GSK image

GSK launches new HIV research centre

May 11, 2015 Research and Development, Sales and Marketing AIDS, GSK, HIV, UNC-Chapel Hill, ViiV, qura

GlaxoSmithKline is boosting its philanthropic efforts in R&D into HIV/AIDS by teaming up with academic researchers to launch a new …
News
harvey_berger

Ariad founder retires

May 11, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ariad, harvey Berger

Dr Harvey Berger the founder of US pharma firm Ariad Pharmaceuticals has announced his decision to retire as chairman and …
Appointment
ViiV founder Dr Manuel Goncalves

Reputation gains from focussing on the patient

May 11, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HIV, Manuel Goncalves, Pfizer, ViiV

Since being spun-off from GSK and Pfizer, specialist HIV firm ViiV Healthcare has earned the best corporate reputation amongst patients …
Feature
Vaccine image

New malaria vaccine found effective in adults

May 8, 2015 Research and Development, Sales and Marketing Oxford, Plasmodium falciparum, Vaccine, malaria

A new malaria vaccine has shown promise in early stage trials, reducing the risk of contracting the disease by two …
News
tom_richards

Havas Lynx Group hires three

May 8, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HAVAS LYNX, bainton, linscott, richards

Havas Lynx Group has just bolstered its ranks with the arrival of three new senior appointments. Jon Linscott joins Tim …
Appointment

Alexion makes $8.4 billion Synageva purchase

May 7, 2015 Research and Development, Sales and Marketing Alexion, Shire, nps, rare disease, synageva

Rare disease specialist firm Alexion is splashing out $8.4 billion to buy fellow US orphan drug developer Synageva biopharmaceuticals. The …
News
Pfizer image

Pfizer names new R&D leaders

May 7, 2015 Research and Development, Sales and Marketing John Lin, Michael Ehlers, Pfizer, rinat

Pfizer has confirmed two key appointments to lead its worldwide research and development organisation with immediate effect. The firm will …
News
michael_zaiac

Celgene appoints European haematology and oncology head

May 7, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Michael Zaiac

Swiss-based Celgene International Sàrl has appointed Michael Zaiac to the position of vice president of medical affairs for its European haematology …
Appointment
screen_shot_2015-05-06_at_15

ABPI appoints head of medical affairs from GSK

May 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Jacintha Sivarajah, acha

The ABPI has appointed Dr Jacintha Sivarajah as the body’s new head of medical affairs. Reporting directly to its executive …
Appointment
screen_shot_2015-05-06_at_11

Lundbeck gains new chief executive from Novo Nordisk

May 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kåre Schultz, Lundbeck, Novo Nordisk, Rebien Sorensen

Danish pharma giant Lundbeck has appointed Kåre Schultz as its new president and chief executive. Schultz (pictured) will take up …
Appointment
GSK image

GSK files ultra-rare disease application with EMA

May 6, 2015 Research and Development, Sales and Marketing EMA, GSK, GSK2696273, Wiskott-Aldrich syndrome, bubble boy, metachromatic leukodystrophy

GlaxoSmithKline has become the first big pharma firm to file for a European marketing authorisation for a gene therapy to …
News
Humira image

AbbVie’s Humira meets endpoint in eye disease study

May 6, 2015 Research and Development, Sales and Marketing AbbVie, FDA, Humira, Zydus Cadila, adalimumab, uveitis

In a Phase III trial AbbVie’s anti-inflammatory medicine Humira has been shown to significantly lower the risk of uncontrolled uveitis …
News
sarret

New chief business officer for Corium

May 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Joseph Sarret, corium

Dr Joseph Sarret has joined commercial-stage US biopharma firm Corium International in the newly-created position of chief business officer. 
Appointment
bayer_chimney

Bayer buys blood-thinning drug from Isis

May 5, 2015 Research and Development, Sales and Marketing Bayer, Eliquis, ISIS-FXI, Isis, Xarelto, blooding thinning

German drug giant Bayer is sealing a $155 million deal with Isis Pharmaceuticals to gain access to its anti-clotting treatment …
News
Keytruda image

Worldwide cancer spending tops $100 billion

May 5, 2015 Research and Development, Sales and Marketing Cancer, IMS Health, keytruda, oncology

Over $100 billion was spent on cancer medicines across the world last year as a new generation of drugs begins …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025